---
title: 'Pharmacist at molecule.xyz'
canonical: 'https://feeny.ai/job/pharmacist-molecule-xyz-germany-s3pkq7vsmz3q'
type: 'job'
last_seen: '2026-09-13'
---

# Pharmacist at molecule.xyz

- **Company:** molecule.xyz
- **Location:** Germany
- **Employment:** full-time
- **Posted:** 2026-06-16
- **Last confirmed live:** 2026-09-13
- **Apply:** https://jobs.ashbyhq.com/molecule/f9b60913-84e7-4bf3-9dec-b4c3c06cf5f9

## Job description

Molecule and BIO.xyz are building the foundation of Decentralized Science (DeSci) — where biotech meets web3 to make scientific research community-owned, transparent, and faster to market. Molecule provides the infrastructure to turn intellectual property (IP) into programmable, on-chain assets through our IP-NFT framework and evolving protocol stack. This enables researchers, patients, and communities to fund and govern biotech projects in new, open ways. [BIO.xyz](http://Bio.xyz) is the coordination and economic layer of DeSci, powering BioDAOs through funding, governance, and ecosystem alignment. Together, we are creating a new model for scientific discovery — one where breakthroughs are owned and advanced by the communities that believe in them. Location: Germany (lab site TBC - right candidate informs final location) Type: Senior IC role - no team to manage on day one; you hire your team in year two once the proof exists

## The Role

Capsules. Tablets. Sterile compounding. We're building precisely-dosed formulations of cognitive, performance, and longevity compounds - modafinil, bromantane, GLP-1 analogs, BPC-157, thymosin α-1, and a growing pipeline of small-molecule and peptide actives. You will set our formulation standards, run the bench work, and be the person who can defend every excipient choice, every dissolution curve, and every sterility result. From active properties to qualified drug product - oral, injectable, topical - with documentation that holds up.

## What You'll Do

- Design oral solid-dose formulations (capsules and tablets) from active properties up - excipient selection, diluents, binders, disintegrants, flow agents, and lubricants matched to each compound's solubility, stability, and dosing profile
- Design sterile injectable formulations for our peptide pipeline - lyophile design, bulking agents, cryoprotectants, vial fill/finish at small scale, reconstitution protocols, and container-closure compatibility. Hands-on with EU GMP Annex 1 (sterile manufacturing) and applicable AMG/AMWHV requirements
- Own encapsulation, blending, and aseptic processing end to end: powder characterization, blend uniformity, content uniformity, capsule fill weight control, scale-up from bench to production batches, and sterility assurance for the injectable side
- Solve hard actives. Bromantane and modafinil bring oral-side challenges - low aqueous solubility, poor flow, dose accuracy at small fill weights. Peptides like BPC-157, GLP-1 analogs, and GHK-Cu bring injectable-side challenges - stability across the lyophile/reconstitution cycle, copper-complex integrity, peptide aggregation. You develop the techniques that make all of them reproducible
- Build and run the analytical backbone: dissolution testing, assay/potency, content and weight uniformity, sterility (Ph. Eur. 2.6.1), endotoxin (Ph. Eur. 2.6.14), and stability programs (ICH Q1A - accelerated and long-term) to establish shelf life
- Write documentation that holds up: master formulation records, batch records, specifications, and SOPs. Define what "in spec" means and enforce it. Clean data trails or it didn't happen
- Partner with sourcing and QC on raw-material specs, incoming API characterization (identity, purity by HPLC, particle size), and supplier qualification. Build a qualified supplier network. Continuously improve - reduce variability, improve stability, lower cost-per-dose without compromising quality

## Who You Are

- Defends decisions with data. You'd rather run the test than guess. When asked why you chose X over Y, you have a data-grounded answer
- High bar on accuracy and sterility. It's people's health. Dose accuracy, reproducibility, and sterility are non-negotiable - especially on injectables
- Expert in the room alone. You work well as the sole expert on day one. No team around you for the first year, and that doesn't slow you down
- Engineers around complexity. You see the regulatory complexity of the compound classes we work with clearly, and you engineer around it rather than pretending it isn't there

Required

- Approbation als Apotheker/in (German pharmacist license), or an EU-recognized pharmacy qualification with a clear path to German licensure. Alternatively: a degree in pharmaceutics, pharmaceutical sciences, or industrial pharmacy (MSc/PhD) with equivalent hands-on formulation depth
- 5+ years of hands-on formulation experience in pharma, nutraceutical, compounding, or contract manufacturing - covering oral solid dose and at least one of: sterile injectables, topicals
- Deep working knowledge of excipient functionality and compatibility, and of encapsulation/tableting unit operations
- Practical command of dissolution, content uniformity, and stability study design and interpretation
- Experience formulating poorly-soluble or low-dose actives
- Working command of EU GMP (EudraLex Vol. 4), Annex 1 (sterile manufacturing), and the Apothekenbetriebsordnung (ApBetrO) or equivalent manufacturing-pharmacy framework
- Rigor with documentation: batch records, specs, SOPs, and a clean data trail

Strongly Preferred

- Sterile injectable / lyophilization experience - peptide formulations specifically
- Background in a German Herstellungsapotheke, hospital pharmacy compounding unit, or EU-licensed contract manufacturer
- Experience formulating GLP-1 analogs (semaglutide, tirzepatide) or other peptide manufacturing under a quality-grade framework
- Familiarity with cognitive/performance compounds, or with the broader peptide / longevity therapeutic landscape
- Hands-on with HPLC, dissolution apparatus, particle sizing, Karl Fischer titration
- Comfort owning scale-up from R&D batches to production
- Working proficiency in German (regulatory and documentation context) and English (team working language)

## What We Offer

- A senior IC seat building the formulation function from scratch at a company at the intersection of biotech, blockchain, and AI
- Pre-approved capex - you spec the equipment: lyophilizer, capsule filler, balance suite, HPLC, dissolution apparatus, Class II BSC
- The team you need, once you've proven the foundation

How to Apply Submit your CV and a Cover Letter describing which formulation problem from our pipeline would you most want to solve? Two paragraphs max on each of (a) which problem, (b) why, and (c) what you'd need to do it well.

We are an equal opportunity employer. We are committed to equality and weaving a community that values diverse perspectives and experiences and are actively seeking a diverse pool of applicants. All employment decisions are made without regard to race, colour, national origin, ancestry, sex, gender, gender identity or expression, sexual orientation, age, genetic information, religion, disability, medical condition, pregnancy, marital status, family status, veteran status, or any other characteristic protected by law.

## About molecule.xyz

## Company Overview
- **One-liner**: Molecule builds onchain infrastructure for tokenizing, funding, and accelerating scientific research, enabling autonomous AI-driven science and liquid intellectual property markets.
- **Entity Type**: Private (Web3 / DeSci startup)
- **Headquarters**: Not publicly available (remote-first, team distributed globally)
- **Founded**: 2020
- **Founders**: Paul Kohlhaas (Founder and Chairman), Aaron Weaver (Chief Commercial Officer, Co-Founder)

## Core Business
- **Primary industry**: Decentralized Science (DeSci), Biotechnology, Web3 Infrastructure
- **Target customers**: Researchers, biotech labs, scientific institutions, Web3 investors, AI agent developers, and pharmaceutical companies
- **Mission**: "Propel science from lab to life, fueled by a community committed to human progress" — democratizing drug development and scientific research funding through onchain infrastructure.

## Products & Services
- **Onchain Lab**: A modular smart contract wallet (ERC-7579) that acts as a sovereign, programmable container for research projects. It holds assets, executes transactions, stores data references, and interacts with protocols under a persistent onchain identity. Supports IP tokenization, fractionalized ownership, and AI agent execution.
- **IP-NFTs & IP Tokens**: Tokenization of intellectual property as NFTs, with fractionalized ownership via tokens, enabling liquid markets for scientific IP, crowdsales, and automated royalty/licensing via smart contracts.
- **Data Infrastructure & DeSci API**: Decentralized data storage (IPFS, Arweave) with provenance tracking, encryption, and granular access control (token-gated, credential-gated, payment-gated). The DeSci API provides programmatic read/write access to Lab data rooms.
- **BioAgents (AI Agent Layer)**: An open-source AI scientist framework (by bio.xyz) integrated as an executor module on Labs. Agents autonomously analyze data, generate hypotheses, and publish findings with full onchain provenance, operating in Fully Autonomous or Human-Directed modes.

## Market Standing
- **Valuation**: Not publicly disclosed
- **Total Funding**: Not publicly disclosed (backed by prominent Web3 and DeSci investors)
- **Notable Investors/Partners**: bio.xyz (ecosystem partner), community of scientists, researchers, and Web3 investors; part of the broader DeSci movement alongside projects like VitaDAO
- **Growth Signals**: Molecule has been operating for over 5 years, evolving from a coordination layer to a full programmable science economy. The launch of "Labs" architecture (Feb 2026) represents a major technical evolution, integrating AI agents (BioAgents) and modular smart contract standards (ERC-4337, ERC-6551, ERC-7579). The platform has successfully tokenized multiple real-world biopharma IP assets, creating a growing ecosystem of onchain science.

## Competitive Advantages
- **First-mover in DeSci infrastructure**: Molecule is one of the earliest and most established platforms for tokenizing biopharma IP onchain, with a track record of real-world scientific assets.
- **Integrated AI agent layer**: The BioAgents integration creates a closed loop where AI agents autonomously operate within Labs, generating hypotheses and analyzing data with full onchain provenance — a unique moat in scientific research infrastructure.
- **Modular, standards-based architecture**: Built on ERC-4337, ERC-6551, and ERC-7579, Labs are sovereign, transferable, and extensible — allowing new capabilities (licensing, governance, oracles) to be installed over time.
- **Liquid IP markets**: IP-NFTs and IP Tokens make traditionally illiquid scientific intellectual property tradable, fractionalizable, and investable — creating a new asset class.

## Strategic Focus
- **Scaling the Labs ecosystem**: Transitioning from a coordination layer to a full programmable science economy where researchers can go from idea to market entirely onchain.
- **AI agent integration**: Deepening the integration of autonomous AI agents (BioAgents) to enable continuous, self-driving scientific research within Labs.
- **Building developer and researcher adoption**: Growing the ecosystem of modules, integrations, and users around the Onchain Lab standard.
- **Tokenizing real-world biopharma IP**: Continuing to bring high-value scientific assets onchain, creating liquid markets for intellectual property.

## Why Work Here
- **Mission-driven**: Directly contribute to accelerating cures and democratizing science funding — work that has tangible impact on human health and progress.
- **Remote-first, global team**: Distributed team with multiple in-person off-sites per year; strong emphasis on autonomy and ownership.
- **Competitive compensation**: Salary + token + equity packages benchmarked against leading biotech and Web3 companies.
- **Generous benefits**: PTO, learning & development budget, paid travel to conferences and scientific events, team off-sites.
- **High-agency culture**: Values include purpose, innovation, autonomy, care, and high standards. The team moves fast, communicates clearly, and values scientific curiosity and operational rigor.
- **Hiring process**: Application → screening → practical hiring challenge (domain-specific) → interviews with teammates and leadership → decision within days. Designed to mimic real work, not trivia.
- **Open roles**: Senior Product Manager, Senior Web3 Engineer, Senior Finance Manager, Full Stack Engineer, dApp Protocol Engineer, and more — all listed on [jobs.ashbyhq.com/molecule](https://jobs.ashbyhq.com/molecule).

## Sources
1. [molecule.xyz](https://molecule.xyz/about-us)
2. [molecule.xyz](https://molecule.xyz/careers)
3. [docs.molecule.xyz](https://docs.molecule.xyz/)
4. [molecule.xyz](https://molecule.xyz/blog/inside-molecules-biggest-technical-overhaul)
5. [molecule.xyz](https://www.molecule.xyz/how-it-works)
6. [jobs.ashbyhq.com](https://jobs.ashbyhq.com/molecule)

## Other roles at molecule.xyz

- [Paralegal](https://feeny.ai/job/paralegal-molecule-xyz-remote-ant91m71jy2q)
- [AI Scientist - Entrepreneur in Residence](https://feeny.ai/job/ai-scientist-entrepreneur-in-residence-molecule-xyz-remote-akb2jmnwjk5c)
- [CEO Attaché](https://feeny.ai/job/ceo-attache-molecule-xyz-remote-tvc8fp16qp6k)
- [Pharmacist](https://feeny.ai/job/pharmacist-purposemed-los-angeles-rqfqbzd27aw7) — Los Angeles, CA
- [Pharmacist](https://feeny.ai/job/pharmacist-waltz-health-chicago-kmvakypxrh3g) — Chicago, IL
- [Pharmacist](https://feeny.ai/job/pharmacist-purposemed-mississauga-f4s11r8w9q12) — Mississauga, Canada